![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 10, 8248-8254, March 8, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
From the
Institute of Physiology, Department of
Membrane Transport, Academy of Sciences of the Czech Republic, 142 20 Prague, Czech Republic and § Institut für Biochemie
der Universität Stuttgart, D-70569 Stuttgart, Germany
Received for publication, July 31, 2001, and in revised form, December 20, 2001
| |
ABSTRACT |
|---|
|
|
|---|
Addition of glucose to Saccharomyces
cerevisiae inactivates the galactose transporter Gal2p and
fructose-1,6-bisphosphatase (FBPase) by a mechanism called
glucose- or catabolite-induced inactivation, which
ultimately results in a degradation of both proteins. It is well
established, however, that glucose induces internalization of Gal2p
into the endocytotic pathway and its subsequent proteolysis in the
vacuole, whereas FBPase is targeted to the 26 S proteasome for
proteolysis under similar inactivation conditions. Here we report that
two distinct proteolytic systems responsible for specific degradation
of two conditionally short-lived protein targets, Gal2p and
FBPase, utilize most (if not all) protein components of the same
glucose sensing (signaling) pathway. Indeed, initiation of
Gal2p and FBPase proteolysis appears to require rapid transport of
those substrates of the Hxt transporters that are at least
partially metabolized by hexokinase Hxk2p. Also, maltose
transported via the maltose-specific transporter(s) generates an
appropriate signal that culminates in the degradation of both proteins.
In addition, Grr1p and Reg1p were found to play a role in transduction
of the glucose signal for glucose-induced proteolysis of Gal2p and
FBPase. Thus, one signaling pathway initiates two different
proteolytic mechanisms of catabolite degradation, proteasomal proteolysis and endocytosis followed by lysosomal proteolysis.
Signal transduction and conversion into different cellular
responses are of utmost importance for cell life and adaptation. It is
the aim of our work to shed some light on the question of how the
nutrient glucose is able to induce two different degradation pathways,
the ubiquitin proteasome-linked hydrolysis of
FBPase1 and the lysosomal
uptake and elimination of the membrane transporter Gal2p, in the yeast
Saccharomyces cerevisiae.
Selective modification by ubiquitin serves as the primary signal, which
confers instability on numerous naturally and/or conditionally short-lived proteins in eukaryotic cells. One well-established role for
the covalent linkage of ubiquitin is to mark cytosolic and nuclear
proteins as well as those proteins that are subjected to endoplasmic
reticulum-associated degradation to hydrolysis by the 26 S proteasome
(1-7). For most of the 26 S proteasome protein targets, the attachment
of a polyubiquitin chain composed of at least four ubiquitin monomer
units linked by isopeptide bonds between Lys48 of ubiquitin
molecules and the C-terminal carboxyl group of the following ubiquitin
facilitates their binding to the proteasome (8, 9). However,
ubiquitination of many short-lived cell surface nutrient transporters,
ion channels, and signal-transducing receptors appears to play no role
in proteasomal proteolysis and signals their internalization into the
endocytotic pathway followed by subsequent proteolysis in the vacuole
instead (1, 10-12). In all known cases of yeast plasma membrane
proteins, a single ubiquitin moiety or di-ubiquitin chains in which
ubiquitin molecules are linked through Lys63 appear to
suffice to trigger their endocytotic uptake and degradation in the
vacuole. Most of the short-lived plasma membrane proteins are
constitutively internalized into the endocytotic system. The rate of
their internalization can be increased by a change in a variety of
parameters such as nutrient availability, binding of substrates or
other ligands, or stress (13). Sugar transporters that are inducible by
their own substrates, including the maltose-specific Mal11p and Mal61p
(14-16), the galactose-specific Gal2p (17, 18), and also the
hexose-specific Hxt6p and Hxt7p (19), represent a group of proteins
that are significantly degraded in the presence of an easily
fermentable carbon source such as glucose. Their degradation occurs by
a mechanism called glucose- or catabolite-induced inactivation due to
apparent analogy with the catabolic inactivation of gluconeogenic
enzymes (20, 21). Glucose-induced inactivation is a process that
occurs upon arrest of cytosolic protein synthesis by either
nitrogen source depletion or the addition of cycloheximide to the
growth medium in combination with glucose (in the case of transporters)
or simply by the addition of glucose (in the case of gluconeogenic
enzymes). Although inactivation conditions and the ultimate fate of the
proteins are similar, the gluconeogenic enzymes and the above-mentioned
sugar transporters are hydrolyzed by two distinct proteolytic systems:
gluconeogenic enzymes are degraded by the 26 S proteasome, whereas
transporters are degraded by the vacuolar proteases.
To identify the mechanism(s) that determines the different fates of
proteins observed during their inactivation, we wanted to elucidate
whether these differences could be due to utilization of distinct
glucose sensing/signaling pathways by different proteolytic systems.
Two proteolytic target proteins undergoing glucose-induced degradation,
FBPase as a substrate of the 26 S proteasome and galactose transporter
Gal2p as a substrate of vacuolar proteases, were chosen. Our previous
studies (17, 18) had revealed that in response to glucose addition to
galactose-grown cells, Gal2p is monoubiquitinated at several lysine
residues. This is triggered through the Ubc1p-Ubc4p-Ubc5p triad of
ubiquitin-conjugating enzymes and the ubiquitin-protein ligase
Npi1p/Rsp5p before transfer of Gal2p to the vacuole, the site of its
degradation. In contrast, upon glucose addition to cells growing on a
nonfermentable carbon source, polyubiquitination of FBPase occurs. This
is also induced by the Ubc1p-Ubc4p-Ubc5p triad of ubiquitin-conjugating
enzymes and, in addition, requires Ubc8p. This modification appears to be essential for its proteolysis by the 26 S proteasome (22-25).
Each extracellular signal must be registered by the cell; thereafter,
the signal must be transduced and ultimately translated into a
biochemical response. For glucose signaling in yeast, a variety of
signal transduction pathways exist, and the ultimate response is a
change in synthesis or degradation of specific sets of proteins. The
main glucose (catabolite) repression pathway (reviewed in Refs.
26-29), the pathway controlling the induction of hexose transporter
genes (reviewed in Refs. 28-31), and the cAMP-protein kinase A pathway
(reviewed in Refs. 29, 32, and 33) are the three best-characterized
pathways that respond to the increased availability of glucose. There
is evidence that some protein components of these pathways, Rgt2p,
Rgt1p, Grr1p, Reg1p, and Hxk2p, are involved in
posttranslational proteolysis of the maltose-specific Mal61p
transporter (34-36). We started our analysis with a search for the
potential functions of the main protein components of glucose sensing
systems in the Gal2p and FBPase proteolysis.
Yeast Strains and Growth and Inactivation Conditions--
The
S. cerevisiae strains used in this study are listed in Table
I. For assays of Gal2p turnover, the
yeast cell cultures were grown in either rich medium (1% yeast extract
and 2% Bacto peptone) or minimal SD medium (0.67% Difco nitrogen base
without amino acids), supplemented with 2% D-galactose
plus 0.02% glucose and auxotrophic requirements. The cells were grown
at 30 °C on a rotary shaker (200 rpm) to an
A600 of 0.5-1.0. To induce the Gal2p
inactivation, the cells were harvested by centrifugation (2500 × g, 4 min), washed with water, and resuspended in 0.17% yeast nitrogen base without ammonium and amino acids plus 2% glucose or any other "inactivating" sugar as indicated to an
A600 of 3. In wild type cells, the effect of
2-deoxy-D-glucose, 6-deoxy-D-glucose, and
3-O-methyl-D-glucose on catabolite degradation
of Gal2p was also tested in the presence of 2%
D-galactose. Similarly, the influence of glucose on the
fate of Gal2p in the Metabolic Labeling and Immunoprecipitation of FBPase--
Yeast
cultures were grown in complete medium (SD medium with amino acid
supplements) without L-methionine (CM-Met) containing 2%
D-glucose until an A600 of 5-6 was
reached. After harvesting and washing with water, the cells were
preincubated in CM-Met medium containing 2% ethanol for 2.5 h at
an A600 of 5. Radiolabeling was done by adding
[35S]methionine (Amersham Biosciences, Inc.) to
the suspension to a final concentration of 45 µCi/ml. After 3.5 h at 30 °C, the cells were collected by centrifugation and
resuspended in complete medium containing 10 mM
L-methionine and 2% glucose or another "inactivating"
sugar. 1-ml samples were taken at the times indicated, and
trichloroacetic acid (final concentration, 5%) was added. The
precipitates were washed with 100 µl of acetone and lysed in 100 µl
of breaking buffer (50 mM Tris-HCl, pH 7.5, 6 M
urea, 1% SDS, and 1 mM EDTA) with glass beads three times
for 5 min with intermittent heating for 1 min at 100 °C. After
cooling, the lysate was diluted with 1 ml of immunoprecipitation buffer (50 mM Tris-HCl, pH 7.5, 190 mM NaCl, 6 mM EDTA, and 1.25% Triton X-100) containing complete
protease inhibitor mix and 1 mM phenylmethylsulfonyl fluoride and centrifuged, and the supernatants were transferred to new
test tubes. FBPase antiserum (3 µl) was added, and the samples were
gently agitated for 2 h at room temperature. Immunoprecipitates were collected by adding a protein A-Sepharose CL-4B suspension (Amersham Biosciences, Inc.; 5% (w/v) in immunoprecipitation buffer) and further incubated for 1 h. The Sepharose beads were
centrifuged (2 min, 3000 rpm) and washed three times with
immunoprecipitation buffer. Proteins were released from Sepharose by
boiling in 50 µl of 2× Laemmli sample buffer (200 mM
Tris-HCl, pH 6.8, 10% SDS, 20% glycerol, and 0.2% bromphenol blue)
for 10 min at 100 °C. Proteins were separated by SDS-PAGE (10%),
and protein bands were quantified with a PhosphorImager (Molecular Dynamics).
Western Blotting Analysis--
Western blot analysis of FBPase
was carried out as described previously for the Gal2p transporter (20),
with one exception; the trichloroacetic acid-precipitated
proteins were solubilized for 40 min at 37 °C and then solubilized
for another 3-4 min at 95 °C. The Gal2p protein and FBPase in the
extracts were detected using anti-Gal2p (1:2000) and anti-FBPase
(1:5000) specific antibodies and the ECL Western blotting kit (Amersham
Biosciences, Inc.). Antibodies to Gal2p were raised against a synthetic
peptide corresponding to amino acids 1-20. The peptide was coupled to
keyhole limpet hemocyanin and used for immunization of rabbits
(Eurogentec). The relative intensities of the Gal2p and FBPase bands at
each time point were quantified by scanning densitometry on
ECL-Hyperfilms.
Components of the cAMP-Protein Kinase A Signal Pathway Are Not
Involved in the Proteolysis of Gal2p and FBPase--
The addition of
rapidly fermentable sugars such as glucose to glucose-depleted cells or
cells grown on nonfermentable carbon sources causes a rapid, transient
peak in intracellular cAMP concentration. This cAMP signal triggers a
cAMP-protein kinase A-mediated protein phosphorylation cascade that
affects numerous targets at both the transcriptional and
posttranslational levels (29, 32, 33). Components of this cAMP pathway
in yeast include the heterotrimeric G protein Gpa2p and,
upstream of Gpa2p, the G protein-coupled receptor Gpr1p, which
stimulate cAMP synthesis by adenylate cyclase Cyr1p in response to
glucose and other easily fermentable carbon sources (37-39).
Activation of cAMP production is also dependent on glucose transport
via Hxt transporters and hexokinase-mediated intracellular
phosphorylation of this sugar, suggesting that glucose is sensed
extracellularly by Gpr1p and intracellularly by hexokinases (29).
Besides Gpa2p, the G proteins Ras1p and Ras2p regulate basal activity
of adenylate cyclase; however, the role of Ras signaling in signal
transmission, if any, is unclear at present.
The fact that the conditions used to trigger proteolysis of the Gal2p
transporter and FBPase also cause an increase in intracellular cAMP
concentration prompted us to examine the fate of these proteins in
gpr1 and gpa2 deletion mutants in response to
glucose. Our data indicate that the rates of Gal2p (Fig.
1A) and FBPase (Fig. 1B) degradation are not altered in the mutant strains as
compared with the wild type. Analogous results were obtained when the
fates of Gal2p and FBPase were measured in a strain carrying a deleted RAM1 gene encoding the The Glucose Sensors Snf3p and Rgt2p and the Putative
Sensor-interacting Proteins Mth1p/Htr1p and Std1p/Msn3p Are Not
Involved in Glucose-induced Proteolysis of Gal2p and
FBPase--
Because in addition to its regulatory functions,
glucose is a nutrient, its presence can be detected by the cells in
several ways: (i) by glucose-specific receptors, (ii) by its
metabolite(s), or (iii) by the metabolic changes it causes. To decide
among these alternatives, we analyzed the fate of Gal2p and FBPase by
measuring their turnover rates in yeast strains carrying deletions in
two genes, SNF3 and RGT2, encoding putative
glucose sensors/receptors using standard inactivation assays. The Snf3p
and Rgt2p proteins are unique members of the hexose transporter (Hxt)
family comprising about 20 proteins related in sequence (40-42). These
two proteins differ from the other Hxt family members in that they are
poorly expressed, control rather than mediate glucose transport, and possess unique, extremely long, presumably cytoplasmic C-terminal tails. They are thought to play a role in glucose sensing at low (Snf3p) and high (Rgt2p) extracellular glucose concentrations (31,
43-45). Immunoblot analysis monitoring the fate of Gal2p and FBPase
indicated a half-life of about 1 h for Gal2p (Fig. 2A) and about 20 min for
FBPase (Fig. 2B) in wild type as well as snf3 and
rgt2 mutant cells. Thus, the rate of proteolysis of both
proteins in response to glucose is not altered in snf3 and rgt2 deletion mutants, indicating that none of the glucose
receptors examined is involved in the signaling pathway for degradation of Gal2p and FBPase.
Recent work has discovered two additional proteins, Mth1p/Htr1p and
Std1p/Msn3p, that may also be components of the glucose induction
mechanism, which regulates HXT gene expression (46-48). Both proteins interact with the C-terminal tails of the glucose sensors
Snf3p and Rgt2p and are presumably involved in the transmission of
glucose signals in the upper part of the glucose sensing/signaling pathway(s). Although our results suggest that a glucose signaling pathway independent of the glucose sensors Snf3p and Rgt2p is involved
in the proteolysis of Gal2p and FBPase, they do not exclude the
requirement of Std1p and Mth1p in this process a priori.
Therefore, we compared the fates of Gal2p and FBPase in wild type
strains with those in std1 and mth1 deletion
mutants. The rates of the Gal2p and FBPase degradation are not
significantly affected in std1 and mth1 mutants
as compared with the wild type strain (data not shown).
Transport and Phosphorylation of Glucose and Certain Related Sugars
Are Necessary and Sufficient to Trigger Proteolysis of Gal2p and
FBPase--
Because metabolism-independent glucose receptors/sensors
Snf3p and Rgt2p are not involved in the detection of extracellular glucose, other obvious candidates for such a function are the general
hexose transporters (Hxt) and glucokinases, which mediate the uptake
and subsequent phosphorylation of intracellular glucose and related
sugars. To decide between glucose itself and its metabolite(s) as the
primary signal for Gal2p and FBPase degradation, we first compared the
fate of both of these proteins in response to glucose, glucose
analogues, and related sugars known or supposed to be the substrates of
Hxt transporters. The selected sugars include the
nonmetabolizable 6-deoxy-D-glucose and
D-fucose, as well as 2-deoxy-D-glucose and
3-O-methyl-D-glucose, which can be
phosphorylated but not metabolized further. Other sugars tested are the
rapidly fermented D-fructose and D-mannose,
which are metabolized like D-glucose but with somewhat
lower efficacy. To unravel whether the signal needed for triggering of
Gal2p and FBPase proteolysis is specific for the substrates of Hxt
transporters or not, the capability of the sugars
D-galactose, D-maltose, raffinose, and sucrose,
which are substrates of other transporters and/or other metabolic
pathways, was examined. Our results are shown in Fig. 3 and are summed up as follows. (i) Gal2p
is not degraded when the nonmetabolizable sugars
6-deoxy-D-glucose and D-fucose, a gratuitous
inducer of Gal2p,2 are
present. However, the presence of 2-deoxy-D-glucose and
3-O-methyl-D-glucose is sufficient for a
relatively rapid degradation of Gal2p (Fig. 3A). Because
degradation of Gal2p is tested under starvation conditions devoid of a
carbon source, the effects of nonmetabolizable sugars on Gal2p
degradation could be due to the lack of ATP production. The ability of
2-deoxy-D-glucose to deplete intracellular ATP pools has
been described previously (49). We therefore examined the fate of Gal2p
in the presence of 2-deoxy-D-glucose,
3-O-methyl-D-glucose, and
6-deoxy-D-glucose and also in the presence of the easily
usable carbon and energy source D-galactose. No differences
in the inactivation patterns were observed (data not shown), indicating
that changes in the ATP content, if any, are not responsible for the
effects observed. (ii) The easily fermentable sugars
D-fructose and D-mannose appear to be
comparably as efficient as glucose in triggering the proteolysis of
Gal2p (Fig. 3A). This is in contrast to the Mal61p
transporter, whose proteolysis is not significantly induced by
D-fructose or D-mannose (36). (iii) Selected
di- and trisaccharides that are split into their monosaccharide
moieties either in the extracellular space (sucrose in most yeast
strains, or raffinose) or after uptake by specific transporters are
hydrolyzed intracellularly (such as maltose, for instance) serve
as "inactivating" sugars to a different extent. Maltose triggers
degradation of Gal2p in galactose-grown wild type cells carrying a
constitutive MAL2-8C allele that causes high
MAL gene expression even in the absence of maltose
(CEN.PK2-1C strain), but not in the wild type W303-1A strain
(mal background) This suggests that transport of maltose has
to occur for initiation of Gal2p degradation (Fig. 3A). (iv) Galactose itself does not lead to significant proteolysis of the Gal2p
transporter. Taken together, our results show that the generation of an
intracellular metabolic signal that initiates proteolysis of the Gal2p
transporter requires transport and at least phosphorylation of the
proper sugar. The signal is not specific for glucose, neither its
transport through Hxt transporters nor its metabolism. The rapid
glucose-triggered inactivation of FBPase does not occur under the same
inactivation conditions used for the Gal2p transporter, whose
proteolysis is strongly accelerated by nitrogen starvation (see here)
or by the addition of cycloheximide, an inhibitor of cytosolic protein
synthesis (17). The presence of cycloheximide or nitrogen starvation
prevents glucose-triggered degradation of FBPase, probably due to
the absence of an "inactivation factor" whose glucose-induced
synthesis is necessary to fulfill this function (50). Moreover,
although glucose immediately stops new synthesis of FBPase in cells
growing in ethanol, it is not clear whether the same effect also occurs
in the presence of other putative "inactivating" sugars. Therefore,
to avoid possible misinterpretations due to the interference of new
synthesis of FBPase with its simultaneous degradation, we examined the
fate of FBPase in response to some glucose analogues and related sugars
by pulse-chase analysis. The results shown in Fig. 3B
demonstrate that FBPase behaves similarly to the Gal2p transporter in
response to different "inactivating" sugars, such as the
easily fermentable D-mannose and D-fructose, which are comparably as efficient as D-glucose. In
contrast, 6-deoxy-D-glucose and D-galactose do
not significantly induce degradation of FBPase. FBPase proteolysis in
galactose-grown strains W303-1A and CEN.PK2-1C is similarly affected by
maltose, as is Gal2p hydrolysis.
The HXK2 Gene Product Plays a Primary Role in the Induction of
Proteolysis of Gal2p and FBPase--
S. cerevisiaecontains
three glucose-phosphorylating enzymes, hexokinase 1, hexokinase 2 (Hxk2p), and glucokinase 1. These enzymes catalyze the first
step in the glycolytic pathway, the phosphorylation of glucose to
glucose-6-phosphate. Hxk2p is primarily responsible for catalyzing this
step of glycolysis when glucose is abundant. It is also required for
transcriptional repression of a large group of genes (MAL,
GAL, SUC2, and so forth; Refs. 26-28), for
generation of a signal for expression of some HXT genes encoding hexose transporters (31), and for the inactivation of Mal61p,
the maltose transporter (36). These properties of Hxk2p are unique and
are not shared by the other two glucose kinases. To further examine the
involvement of the above-mentioned glucokinases in the degradation of
Gal2p and FBPase, we compared their fate in mutants carrying
single or multiple mutations in these kinases. Glucose-induced
proteolysis of Gal2p (Fig. 4A)
and FBPase (Fig. 4C) is similar to that of the wild type in
strains expressing Hxk2p as the only glucose kinase. Interestingly, the
rate of Gal2p degradation was more rapid in the mutant strain
expressing only Hxk2p than in the wild type strain. A similar effect
has also been observed with Mal61p inactivation and proteolysis (35). Deletion of HXK2 completely abolishes degradation of Gal2p
(Fig. 4B) and FBPase (Fig. 4D), whereas
deletion of none of the other kinases (glucokinase 1 and hexokinase 1)
affects proteolysis of the two proteins. As expected, no degradation of
Gal2p and FBPase occurs in the strain missing all three glucokinases.
To exclude the possibility that the inability of glucose to induce
Gal2p degradation in the glucokinase triple mutant is due to
insufficient ATP, we also examined the fate of Gal2p in the presence of
glucose and galactose. No alteration in the block of Gal2p degradation was observed (data not shown). These findings strongly support the view
that Hxk2p alone is sufficient for full generation of the glucose
signal triggering degradation of both enzymes.
The Roles of GRR1, RGT1, and REG1 Gene Products in Glucose-induced
Proteolysis of Gal2p and FBPase--
We also examined the fate of
Gal2p and FBPase in mutant strains defective in three additional genes,
GRR1, RGT1, and REG1, encoding
putative downstream effectors of the pathway. Because mutations in the
GRR1 gene relieve the repression of numerous glucose-repressed genes (51) and prevent glucose induction of some
HXT genes (52), Grr1p was suggested to play a central role in the transcriptional regulation by glucose. Genetic analysis suggested that Grr1p inhibits the function of Rgt1p, a zinc finger containing DNA-binding transcription factor that functions as a
transcriptional repressor in the absence of glucose and as a transcriptional activator at high glucose concentrations, thereby causing de-repression of HXT gene expression (31, 53). In addition to its role in regulating Rgt1p, Grr1p has a variety of
functions (34, 54-57) that may be unrelated to glucose-induced signal
transduction. Reg1p is a regulatory subunit of Glc7p protein phosphatase type 1 that directs the catalytic subunit of the enzyme to
proteins involved in transcriptional repression of several genes by
glucose (28). It is furthermore involved in the induction of
proteolysis of the Mal61p transporter (36). When following the fate of
Gal2p (Fig. 5A) and FBPase
(Fig. 5B) in grr1, rgt1, and
reg1 deletion mutants, we found that their proteolysis is significantly disturbed in grr1 and almost completely
blocked in reg1 mutants, whereas the rate of their
proteolysis observed in the rgt1 mutant is comparable with
the rate measured in the wild type strain. Our results thus indicate
that Grr1p and Reg1p are central components of the glucose signal
transduction mechanism responsible for glucose-induced proteolysis of
both Gal2p and FBPase.
Glucose-induced degradation of the plasma membrane-located Gal2p
transporter and of cytoplasmic FBPase follows different proteolytic pathways: Gal2p is endocytosed and degraded via vacuolar proteases, whereas FBPase is degraded by the 26 S proteasome. We show that the
nature of the pathway selected is not due to different initiating signals generated by distinct glucose sensing/signaling pathways. Recent analyses of proteins involved in glucose-triggered inactivation and proteolysis of the plasma membrane-localized maltose transporter Mal61p in yeast revealed the function of two glucose signaling pathways
called pathway 1 and pathway 2 that contribute to this process
(34-36). Pathway 1 is a glucose transport-independent pathway in which
glucose probably binds to the glucose sensor Rgt2p and generates a
signal, which is transmitted through the Grr1p protein followed by
proteolysis of Mal61p. In pathway 2, rapid transport and metabolism of
glucose and/or some other sugars yield an unknown glucose metabolite(s)
sufficient to generate an intracellular signal. This is transmitted via
signal transducers, which are composed of regulator subunits Reg1p and
Reg2p of the Glc7p protein phosphatase type 1.
The results presented here are consistent with the view that glucose
signaling pathway 2 generates the major signals that initiate
proteolysis of Gal2p and FBPase. Proteolysis of both model proteins
appears to be independent of Snf3p and Rgt2p, the putative glucose
sensors/receptors (Fig. 2, A and B).
Interestingly, the same result, independence of Snf3p and Rgt2p, was
also found for proteolysis of the Hxt6p and Hxt7p glucose transporters
in response to high external glucose concentrations (19). Based on our
examination of the fate of Gal2p and FBPase in response to glucose,
glucose analogues, and related sugars, several conclusions can be
drawn. Transport and at least sugar phosphorylation are prerequisites
for generation of a signal initiating proteolysis of Gal2p and FBPase.
6-Deoxy-D-glucose and D-fucose are not
phosphorylated and do not induce proteolysis (Fig. 3). The strict
requirement for phosphorylation of sugars suggests that the sensing
mechanism probably does not likely operate at the level of sugar
transport. Also consistent with such a view is our finding that
maltose, the substrate of maltose-specific transporters, is able to
elicit a signal needed for proteolysis of Gal2p in a galactose-grown strain that constitutively synthesizes the maltose transporter. The
ability of 2-deoxy-D-glucose and
3-O-methyl-D-glucose, two phosphorylated glucose
analogues, to induce degradation of Gal2p, also firmly substantiates
the necessity of phosphorylation of the appropriate sugar for the
different Gal2p and FBPase degradation pathways. Hxk2p is the most
active enzyme of the three yeast glucokinases catalyzing
phosphorylation of glucose at C6. In addition, it is rather
specifically required for a variety of regulatory effects, including
transcriptional repression and/or induction of certain genes as well as
posttranslational inactivation of the maltose transporter. Hxk2p exists
in a phosphorylated monomer-unphosphorylated dimer equilibrium, and the
available data suggest that the state of phosphorylation is essential
for at least transcriptional repression and induction (58).
Nevertheless, the molecular basis of its exact function in glucose
signaling remains unclear. Our knowledge about the role(s) of Hxt2p in
glucose sensing stems mainly from an analysis of the main repression
pathway in yeast strains carrying different hxk2 mutant
alleles. In most of these hxk2 mutants, glucose repression
appears to inversely correlate with the phosphorylation activity of
Hxk2p. However, in some mutant strains, the catalytic and regulatory
functions of Hxk2p are at least partially uncoupled, suggesting that
not just the catalytic activity of the enzyme may be important for its
role in glucose sensing. Our results shown in Fig. 4, A and
B, indicate that Hxk2p plays a major, if not exclusive, role
in the pathway whose ultimate result is proteolysis of Gal2p and
FBPase. D-Galactose catabolism bypasses the hexokinases in
galactose-grown cells: galactose is phosphorylated via galactose kinase, Gal1p. The molecule also finally yields the glucose derivative glucose-6-phosphate, but without catalysis by Hxk2p. This might argue
that only hexose-binding, catalytically active Hxk2p can exert a
signaling function. This view is supported by the observation that
deletion of the two other kinases, hexokinase 1 and glucokinase 1, increases the degradation rate of Gal2p as compared with the wild type
(Fig. 4A). Their absence must increase the glucose
concentration, which can interact solely with Hxk2p in the mutants.
Only actively catalyzing Hxk2p might expose a domain at its surface,
which is able to transmit a signal. There is still the possibility that the intracellular glucose-6-phosphate concentration necessary to
trigger proteolysis of Gal2p and FBPase is attained in response to
glucose but not galactose addition. There is also the possibility that
Hxk2p may have some noncatalytic role in sensing and/or signaling required for proteolysis of Gal2p and FBPase. The strong inhibition of
glucose-induced degradation of Gal2p and FBPase observed in grr1 and reg1 deletion mutants (Fig. 5,
A and B) suggests that the GRR1 and
REG1 gene products may function as downstream components of
the glucose sensing/signaling pathway. However, grr1
mutations are very pleiotropic (34, 51, 52, 54-56), and we do not know at present whether the contribution of Grr1p to glucose-induced degradation of Gal2p and/or FBPase is direct or indirect (for a
summary, see Fig. 6). Studies in this
direction, as well as attempts to elucidate mutual interactions between
downstream effectors Grr1p, Rgt1p, and Reg1p and their functional
consequences, are in progress.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
hxk1
hxk2
glk1 triple mutant was
tested in the presence of 2% D-galactose. The cell samples
were taken at the times indicated below over a 6-h period, and for each
sample, total cell extracts were prepared for Western analysis as
described previously (18). For assays of FBPase turnover, the overnight
cell cultures grown on rich medium in the presence of 2%
D-glucose were diluted 1:100 in the same medium and grown
for additional 6-7 h. Then the cells were washed, resuspended in rich
medium containing 2% ethanol to an A600 of 0.5, and grown for an additional 16-17 h to de-repress FBPase (final
A600 = 4-5). To induce FBPase inactivation,
D-glucose was added to 2% concentration to the cell
suspension at an A600 of 3, and cell samples
were taken at the times indicated below over 1-2 h. For each sample,
total cell extracts were prepared for Western analysis. When other
sugars were used for FBPase inactivation, pulse-chase analysis was done
(see below).
S. cerevisiae strains used in this study
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
-subunit of protein
farnesyltransferase, which modifies the Ras protein (data not
shown).

View larger version (38K):
[in a new window]
Fig. 1.
Glucose-induced degradation of the Gal2p
transporter and FBPase is independent of the Gpr1p-Gpa2p G
protein-coupled receptor system. Strains BY4743 (parental strain),
gpr1
, and gpa2
were grown to exponential
phase on rich medium containing 2% galactose plus 0.02% glucose
(A) or 2% ethanol (B). For controls, the
gal2
strain (
in A) was grown on rich
medium containing raffinose (2%) instead of glucose, whereas the
fbp1
strain (
in B) was grown as the
wild type strain. Standard inactivation protocols were used as
described under "Materials and Methods." At the indicated times,
total cell extracts were prepared, and the proteins were subjected to
Western blot analysis with Gal2p (A)- and FBPase
(B)-specific polyclonal antibodies. The intensity of the
protein bands present in the immunoblots was quantified by scanning
densitometry.

View larger version (65K):
[in a new window]
Fig. 2.
Putative glucose sensors/receptors Snf3p and
Rgt2p do not play any role in glucose-induced degradation of Gal2p and
FBPase. Analysis of Gal2p (A) and FBPase (B)
in strains CEN.PK2-1C (parental strain), SK1 (snf3
), and
SK2 (rgt2
) was performed as described in the Fig. 1
legend.

View larger version (47K):
[in a new window]
Fig. 3.
Proteolysis of Gal2p and FBPase in the
presence of different sugars. A, analysis of Gal2p in wild
type strain W303-1A was done as described in the Fig. 1 legend. The
ability of D-maltose to induce proteolysis of Gal2p
(A) was measured in W303-1A (maltose (1); mal
background) and CEN.PK2-1C (maltose (2);
MAL2-8C background) wild type strains. B,
the fate of FBPase in response to the representative group of sugars
was followed in the same wild type cells by pulse-chase analysis as
described under "Materials and Methods." Gal,
D-galactose; Fru, D-fructose;
Man, D-mannose; Fuc,
D-fucose; 6dGlc, 6-deoxy-D-glucose;
2dGlc, 2-deoxy-D-glucose; 3mGlc,
3-O-methyl-D-glucose; Raf,
D-raffinose; Suc, sucrose; Mal,
D-maltose.

View larger version (37K):
[in a new window]
Fig. 4.
Hexokinase Hxk2p plays a dominant role
in Gal2p and FBPase degradation. Analysis of Gal2p (A
and B) and FBPase (C and D)
degradation was done in two sets of isogenic strains. The first set
consisted of strains W303-1A (parental strain), YSH7.4-11A
(hxk1HXK2glk1), and YSH7.4-3C (hxk1hxk2glk1)
(A and B). The other set consisted of strains
BY4743 (parental strain) and hxk1, hxk2, and
glk1 single deletion strains (B and
D). For an analysis of FBPase degradation, the cells were
grown on 2% D-galactose before enzyme de-repression in a
2% ethanol medium. Inactivation of Gal2p and FBPase was started by the
addition of 2% D-glucose.

View larger version (51K):
[in a new window]
Fig. 5.
Glucose-induced proteolysis of Gal2p and
FBPase requires the presence of functional GRR1 and
REG1 gene products. Analyses of Gal2p
(A) and FBPase (B) in BY4743 (parental strain)
and grr1
, rgt1
, and reg1
mutant strains were done as described in the Fig. 1 legend.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

View larger version (23K):
[in a new window]
Fig. 6.
Key protein components of the glucose
signaling pathway responsible for glucose-triggered proteolysis of the
Gal2p transporter and FBPase. Red script set on a
blue tone, proteins excluded from signaling Gal2p and
FBPase proteolysis. Blue script set on a yellow
tone, proteins necessary for signaling Gal2p and FBPase
proteolysis. PM, plasma membrane.
The chemical nature of the signal(s) initiating glucose-induced
degradation of Gal2p and FBPase is unknown. The ATP:AMP ratio or its
change during repression/de-repression of yeast genes observed in
response to the availability of glucose led to a proposal that this
ratio might act as a signal for the glucose repression pathway (59).
Although the same signal might also serve as a messenger in other
glucose-regulated processes, including posttranslational inactivation
and/or proteolysis of some proteins, it nevertheless remains possible
that the glucose metabolites glucose-6-phosphate, UDP-glucose, or
trehalose may fulfill this function.
| |
ACKNOWLEDGEMENTS |
|---|
We thank E. Boles and J. M. Thevelein for kindly providing strains and A. Kruckeberg for an initial supply of anti-Gal2p antibodies. We thank Zuzana Syková for technical assistance. We also thank Frank Josupeit and Elisabeth Tosta for expert help with preparation of the manuscript.
| |
FOOTNOTES |
|---|
* This work was supported by Grants 204/01/0272, 204/02/1240, and IAA50 11005 from the Grant Agency of the Czech Republic, the Deutsche Forschungsgemeinschaft, Bonn, SFB 495 and the Fonds der Chemischen Industrie, Frankfurt.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed: Institut für Biochemie, Universität Stuttgart, Pfaffenwaldring 55, D-70569 Stuttgart, Germany. Tel.: 49-711-685-4390; Fax: 49-711-685-4392; E-mail: dieter.wolf@po.uni-stuttgart.de.
Published, JBC Papers in Press, December 28, 2001, DOI 10.1074/jbc.M107255200
2 J. Horak, J. Regelmann, and D. H. Wolf, unpublished data.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: FBPase, fructose-1,6-bisphosphatase; Hxk2p, hexokinase 2.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Bonifacino, J. S., and Weissman, A. M. (1998) Annu. Rev. Cell Dev. Biol. 14, 19-57[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | Hershko, A., and Ciechanover, A. (1998) Annu. Rev. Biochem. 67, 425-479[CrossRef][Medline] [Order article via Infotrieve] |
| 3. | Hilt, W., and Wolf, D. H. (1996) Trends Biochem. Sci. 21, 96-102[CrossRef][Medline] [Order article via Infotrieve] |
| 4. | Hochstrasser, M. (1996) Annu. Rev. Genet. 30, 405-439[CrossRef][Medline] [Order article via Infotrieve] |
| 5. | Pickart, C. M. (1997) FASEB J. 11, 1055-1066[Abstract] |
| 6. | Plemper, R. K., and Wolf, D. H. (1999) Trends Biochem. Sci. 24, 266-270[CrossRef][Medline] [Order article via Infotrieve] |
| 7. | Hilt, W., and Wolf, D. H. (2000) Proteasomes: The World of Regulatory Proteolysis , pp. 1-387, Landes Bioscience, GeorgetownEurekah.com, Austin |
| 8. |
Chau, V.,
Tobias, J. W.,
Bachmair, A.,
Marriott, D.,
Ecker, D. J.,
Gonda, D. K.,
and Varshavsky, A.
(1989)
Science
243,
1576-1583 |
| 9. | Thrower, J. S., Hofman, L., Rechsteiner, M., and Pickart, C. M. (2000) EMBO J. 19, 94-102[CrossRef][Medline] [Order article via Infotrieve] |
| 10. | Hicke, L. (1999) Trends Cell Biol. 9, 107-112[CrossRef][Medline] [Order article via Infotrieve] |
| 11. | Hicke, L. (2001) Nat. Rev. Mol. Cell. Biol. 2, 195-201[CrossRef][Medline] [Order article via Infotrieve] |
| 12. | Rotin, D., Staub, O., and Haguenauer-Tsapis, R. (2000) J. Membr. Biol. 176, 1-17[CrossRef][Medline] [Order article via Infotrieve] |
| 13. | Horak, J. (1997) Biochim. Biophys. Acta 1331, 41-79[Medline] [Order article via Infotrieve] |
| 14. | Lucero, P., Herweijer, M., and Lagunas, R. (1993) FEBS Lett. 333, 165-168[CrossRef][Medline] [Order article via Infotrieve] |
| 15. |
Medintz, I.,
Jiang, H.,
Han, E. K.,
Cui, W.,
and Michels, C. A.
(1996)
J. Bacteriol.
178,
2245-2254 |
| 16. |
Riballo, E.,
Herweijer, M.,
Wolf, D. H.,
and Lagunas, R.
(1995)
J. Bacteriol.
177,
5622-5627 |
| 17. |
Horak, J.,
and Wolf, D. H.
(1997)
J. Bacteriol.
179,
1541-1549 |
| 18. |
Horak, J.,
and Wolf, D. H.
(2001)
J. Bacteriol.
183,
3083-3088 |
| 19. | Krampe, S., Stamm, O., Hollenberg, C. P., and Boles, E. (1998) FEBS Lett. 441, 343-347[CrossRef][Medline] [Order article via Infotrieve] |
| 20. | Holzer, H. (1976) Trends Biochem. Sci. 1, 178-181 |
| 21. | Holzer, H. (1989) Cell Biol. Rev. 21, 305-319 |
| 22. |
Hämmerle, M.,
Bauer, J.,
Rose, M.,
Szallies, A.,
Thumm, M.,
Dusterhus, S.,
Mecke, D.,
Entian, K.-D.,
and Wolf, D. H.
(1998)
J. Biol. Chem.
273,
25000-25505 |
| 23. | Schork, S. M., Bee, G., Thumm, M., and Wolf, D. H. (1994) FEBS Lett. 349, 270-274[CrossRef][Medline] [Order article via Infotrieve] |
| 24. |
Schork, S. M.,
Thumm, M.,
and Wolf, D. H.
(1995)
J. Biol. Chem.
270,
26446-26450 |
| 25. | Schüle, T., Rose, M., Entian, K.-D., Thumm, M., and Wolf, D. H. (2000) EMBO J. 19, 2161-2171[CrossRef][Medline] [Order article via Infotrieve] |
| 26. | Carlson, M. (1999) Curr. Opin. Microbiol. 2, 202-207[CrossRef][Medline] [Order article via Infotrieve] |
| 27. |
Gancedo, J. M.
(1998)
Microbiol. Mol. Biol. Rev.
62,
334-361 |
| 28. | Johnston, M. (1999) Trends Genet. 15, 29-33[CrossRef][Medline] [Order article via Infotrieve] |
| 29. | Rolland, F., Winderickx, J., and Thevelein, J. M. (2001) Trends Biochem. Sci. 26, 304-310[CrossRef][Medline] [Order article via Infotrieve] |
| 30. | Kruckeberg, A. L., Walsh, M. C., and Van Dam, K. (1998) Bioessays 20, 972-976[CrossRef][Medline] [Order article via Infotrieve] |
| 31. | Özcan, S., Leong, T., and M. Johnston, M. (1996) Microbiol. Mol. Biol. Rev. 63, 554-569 |
| 32. | Thevelein, J. M., and de Winde, J. H. (1999) Mol. Microbiol. 33, 904-918[CrossRef][Medline] [Order article via Infotrieve] |
| 33. | Thevelein, J. M., Cauwenberg, L., Colombo, S., de Winde, J. H., Donaton, M., Dumortier, F., Kraakman, L., Lemaire, K., Ma, P., Nauwelaers, D., Rolland, F., Teunissen, A., Van Dijck, P., Versele, M., Wera, S., and Winderickx, J. (2000) Enzyme Microb. Technol. 26, 819-825[CrossRef][Medline] [Order article via Infotrieve] |
| 34. | Jiang, H., Medintz, I., and Michels, C. A. (1997) Mol. Biol. Cell 8, 1293-1304[Abstract] |
| 35. |
Jiang, H.,
Medintz, I.,
Zhang, B.,
and Michels, C. A.
(2000)
J. Bacteriol.
182,
647-654 |
| 36. | Jiang, H., Tatchell, K., Liu, S., and Michels, C. A. (2000) Mol. Gen. Genet. 263, 411-422[CrossRef][Medline] [Order article via Infotrieve] |
| 37. | Colombo, S., Ma, P., Cauwenberg, L., Winderickx, J., Crauwels, M., Teunissen, A., Nauwelaers, D., de Winde, J. H., Gorwa, M.-F., Colavizza, D., and Thevelein, J. M. (1998) EMBO J. 17, 3326-3341[CrossRef][Medline] [Order article via Infotrieve] |
| 38. | Kraakman, L., Lemaire, K., Ma, P., Teunissen, A. W. R. H., Donaton, M. C. V., Van Dijck, P., Winderickx, J., de Winde, J. H., and Thevelein, J. M. (1999) Mol. Microbiol. 32, 1002-1012[CrossRef][Medline] [Order article via Infotrieve] |
| 39. | Xue, Y., Batlle, M., and Hirsch, J. P. (1998) EMBO J. 17, 1996-2000[CrossRef][Medline] [Order article via Infotrieve] |
| 40. | Boles, E., and Hollenberg, C. P. (1997) FEMS Microbiol. Rev. 21, 85-111[CrossRef][Medline] [Order article via Infotrieve] |
| 41. | Kruckeberg, A. L. (1996) Arch. Microbiol. 166, 283-292[CrossRef][Medline] [Order article via Infotrieve] |
| 42. | Wieczorke, R., Krampe, S., Weierstall, T., Freidel, K., Hollenberg, C. P., and Boles, E. (1999) FEBS Lett. 464, 123-128[CrossRef][Medline] [Order article via Infotrieve] |
| 43. | Liang, H., and Gaber, R. E. (1996) Mol. Biol. Cell 7, 1953-1966[Abstract] |
| 44. |
Özcan, S.,
Dover, J.,
Rosenwald, A.,
Wolfl, S.,
and Johnston, M.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
12428-12432 |
| 45. | Özcan, S., Dover, J., and Johnston, M. (1998) EMBO J. 17, 2566-2573[CrossRef][Medline] [Order article via Infotrieve] |
| 46. | Lafuente, M. J., Gancedo, C., Jauniaux, J.-C., and Gancedo, J. M. (2000) Mol. Microbiol. 35, 161-172[CrossRef][Medline] [Order article via Infotrieve] |
| 47. |
Schmidt, M. C.,
McCartney, R. R.,
Zhang, X.,
Tillman, T. S.,
Solimeo, H.,
Wölfl, S.,
Almonte, C.,
and Watkins, S. C.
(1999)
Mol. Cell. Biol.
19,
4561-4571 |
| 48. |
Schulte, F.,
Wieczorke, R.,
Hollenberg, C. P.,
and Boles, E.
(2000)
J. Bacteriol.
182,
540-542 |
| 49. | Beullens, M., and Thevelein, J. M. (1990) Curr. Microbiol. 21, 39-46 |
| 50. |
Chiang, H.-L.,
Schekman, R.,
and Hamamoto, S.
(1996)
J. Biol. Chem.
271,
9934-9941 |
| 51. |
Flick, J. S.,
and Johnston, M.
(1991)
Mol. Cell. Biol.
11,
5101-5112 |
| 52. | Özcan, S., and Johnston, M. (1995) Mol. Cell. Biol. 15, 1564-1572[Abstract] |
| 53. | Özcan, S., Leong, T., and Johnston, M. (1996) Mol. Cell. Biol. 16, 6419-6426[Abstract] |
| 54. |
Iraqui, I.,
Vissers, S.,
Bernard, F.,
de Craene, J. O.,
Boles, E.,
Urresterazu, A.,
and Andre, B.
(1999)
Mol. Cell. Biol.
19,
989-1001 |
| 55. | Bernard, F., and André, B. (2001) FEBS Lett. 496, 81-85[CrossRef][Medline] [Order article via Infotrieve] |
| 56. | Li, F. N., and Johnston, M. (1997) EMBO J. 16, 5629-5638[CrossRef][Medline] [Order article via Infotrieve] |
| 57. |
Barral, Y.,
Jentsch, S.,
and Mann, C.
(1995)
Genes Dev.
9,
399-409 |
| 58. |
Randez-Gil, F.,
Sanz, P.,
Entian, K.-D.,
and Prieto, J. A.
(1998)
Mol. Cell. Biol.
18,
2940-2948 |
| 59. | Wilson, W. A., Hawley, S. A., and Hardie, D. G. (1996) Curr. Biol. 6, 1426-1434[CrossRef][Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
G. M. Santangelo Glucose Signaling in Saccharomyces cerevisiae Microbiol. Mol. Biol. Rev., March 1, 2006; 70(1): 253 - 282. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-C. Hung, C. R. Brown, A. B. Wolfe, J. Liu, and H.-L. Chiang Degradation of the Gluconeogenic Enzymes Fructose-1,6-bisphosphatase and Malate Dehydrogenase Is Mediated by Distinct Proteolytic Pathways and Signaling Events J. Biol. Chem., November 19, 2004; 279(47): 49138 - 49150. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Dombek, N. Kacherovsky, and E. T. Young The Reg1-interacting Proteins, Bmh1, Bmh2, Ssb1, and Ssb2, Have Roles in Maintaining Glucose Repression in Saccharomyces cerevisiae J. Biol. Chem., September 10, 2004; 279(37): 39165 - 39174. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-Y. Cui, C. R. Brown, and H.-L. Chiang The Type 1 Phosphatase Reg1p-Glc7p Is Required for the Glucose-induced Degradation of Fructose-1,6-bisphosphatase in the Vacuole J. Biol. Chem., March 12, 2004; 279(11): 9713 - 9724. [Abstract] [Full Text] [PDF] |
||||
|
|